Dogwood Therapeutics DWTX Ratios & Valuation
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Liquidity | ||||||
| Current ratio | 5.9×-1.6× | 2.8×-2.5× | 4.5×+2.8× | 7.8×+0.5× | 7.4×+1.8× | |
| Leverage | ||||||
| Debt-to-equity | 0×— | 0×— | —— | —— | —— | |
| Per Share | ||||||
| Book value per share | $2.40-51.1% | $15.05+253% | $3.78+342% | $3.60+5.1% | $4.92+42.7% | |
| Valuation | ||||||
| Market capitalization | $54.14M-57.6% | $123.67M— | $228.9M— | —— | —— | |
| Price / book | 0.6×-16.6× | 1.7×— | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do Dogwood Therapeutics's ratios come from?
- Every ratio is computed from Dogwood Therapeutics's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.